Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Large Cedars-Sinai Study Identifies High-Risk Prostate Cancer with New Type of Analysis

In the largest study of its kind, scientists at Cedars-Sinai have developed a new classification system that could be used to predict whether prostate cancer in patients is likely to progress into a fatal form of the disease.

The research from the Los Angeles-based Cedars-Sinai analyzed more than 4,600 prostate cancer specimens. It is the first large-scale study to link clinical outcomes to subtypes based on the processes by which genes are turned on and off in the cancer cells.

Read the full article here.

source: Life Science Daily